Cibc World Markets Corp Charles River Laboratories International, Inc. Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 6,962 shares of CRL stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,962

Previous 6,673 4.33%

Holding current value

$1.39 Million

Previous $1.38 Million 0.51%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $54,320 - $70,888	289 Added 4.33%	6,962 $1.37 Million
Q2 2024 Aug 12, 2024	BUY	$206.39 - $268.73 $321,968 - $419,218	1,560 Added 30.51%	6,673 $1.38 Million
Q1 2024 May 13, 2024	SELL	$203.52 - $273.43 $301,616 - $405,223	-1,482 Reduced 22.47%	5,113 $1.39 Million
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $619,417 - $899,232	3,765 Added 133.04%	6,595 $1.56 Million
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $617,930 - $691,564	-3,178 Reduced 52.9%	2,830 $554,000
Q2 2023 Aug 04, 2023	BUY	$183.71 - $210.25 $631,043 - $722,208	3,435 Added 133.5%	6,008 $1.26 Million
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $653,961 - $885,807	-3,408 Reduced 56.98%	2,573 $519,000
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $1.18 Million - $1.5 Million	5,981 New	5,981 $1.3 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $1.4 Million - $2.07 Million	-6,837 Reduced 65.84%	3,547 $759,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $221,527 - $313,949	867 Added 9.11%	10,384 $2.95 Million
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $651,809 - $832,301	-1,855 Reduced 16.31%	9,517 $3.59 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $2.94 Million - $3.61 Million	7,883 Added 225.94%	11,372 $4.69 Million
Q2 2021 Aug 10, 2021	SELL	$294.17 - $371.65 $545,685 - $689,410	-1,855 Reduced 34.71%	3,489 $1.29 Million
Q1 2021 May 07, 2021	BUY	$249.67 - $299.48 $1.33 Million - $1.6 Million	5,344 New	5,344 $1.55 Million
Q1 2020 May 12, 2020	SELL	$98.9 - $178.34 $2.46 Million - $4.44 Million	-24,900 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $3.14 Million - $3.8 Million	24,900 New	24,900 $3.8 Million
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $16.6 Million - $19 Million	-132,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$123.4 - $148.55 $10.1 Million - $12.1 Million	81,500 Added 159.8%	132,500 $18.8 Million
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $4.5 Million - $5.87 Million	42,800 Added 521.95%	51,000 $5.77 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $919,302 - $1.1 Million	8,200 New	8,200 $1.1 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Charles River Laboratories International, Inc. Transaction History